Scholars@Duke
construction release_alert
Profile editing is temporarily unavailable from June 11-24, 2026 while manual profile data entry transitions to Elements. Learn More.
cancel

Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies

Publication ,  Journal Article
Segura, T
Published in: Handbook of Pharmaceutical Biotechnology
2007

Duke Scholars

Tatiana Segura
Author Tatiana Segura Biomedical Engineering

Published In

Handbook of Pharmaceutical Biotechnology

Publication Date

2007

Start / End Page

1013 / 1059

Publisher

John Wiley & Sons, Inc.
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Segura, T. (2007). Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies. Handbook of Pharmaceutical Biotechnology, 1013–1059.
Segura, Tatiana. “Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies.” Handbook of Pharmaceutical Biotechnology, 2007, 1013–59.
Segura T. Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies. Handbook of Pharmaceutical Biotechnology. 2007;1013–59.
Segura, Tatiana. “Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies.” Handbook of Pharmaceutical Biotechnology, John Wiley & Sons, Inc., 2007, pp. 1013–59.
Segura T. Formulations and Delivery Limitations of Nucleic-Acid-Based Therapies. Handbook of Pharmaceutical Biotechnology. John Wiley & Sons, Inc.; 2007;1013–1059.

Published In

Handbook of Pharmaceutical Biotechnology

Publication Date

2007

Start / End Page

1013 / 1059

Publisher

John Wiley & Sons, Inc.